Literature DB >> 19784817

Clinical features of early recurrent myocardial infarction.

Kenichi Sakakura1, Norifumi Kubo, Junya Ako, Nahoko Ikeda, Hiroshi Funayama, Taishi Hirahara, Hiroshi Wada, Yoshitaka Sugawara, Takanori Yasu, Masanobu Kawakami, Shin-ichi Momomura.   

Abstract

Recurrence of myocardial infarction, especially when occurring early after the prior one, carries a significant morbidity and mortality rate. The aim of this study was to investigate the characteristics of patients who experienced recurrence under secondary prevention therapy. Case record review identified myocardial infarction patients who had a history of previous myocardial infarction within 5 years. Hospital chart records, initial laboratory data, medications, and type of infarction were reviewed. Patients were divided into two groups according to the interval of recurrence: an early group (recurrence within 1 year), and a late group (recurrence after more than 1 year). A total of 89 patients were included in the analysis; 40 patients in the early group, and 49 patients in the late group. Mean age in the early group and late groups was 67.3 +/- 11.9 and 59.4 +/- 8.9, respectively (P = 0.001). Mean body mass index in the early and late groups was 22.1 +/- 3.6 and 25.0 +/- 3.3, respectively (P < 0.001). There were fewer current smokers in the early group (7.5% vs 44.9%, P < 0.001) and more stent thrombosis (17.5% vs 2%, P = 0.02), as compared with the late group. The in-hospital mortality rate tended to be higher in the early group (7.5% vs 0%, P = 0.09). Multiple logistic regression revealed that smoking status (odds ratio [OR] 0.09, 95% confidence interval [CI] 0.02-0.49, P = 0.005), HDL cholesterol level (5 mg/dl increase: OR 1.34, 95% CI 1.04-1.74, P = 0.03), and stent thrombosis (OR 35.59, 95% CI 2.13-595.49, P = 0.01) had significant associations with early recurrence. Early recurrence of myocardial infarction was associated with stent thrombosis, a higher HDL cholesterol level, and a lower frequency of smoking. Early recurrence had a trend toward higher mortality than late recurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784817     DOI: 10.1007/s00380-008-1133-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  22 in total

1.  In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study.

Authors:  G K Andrikopoulos; D J Richter; P E Dilaveris; A Pipilis; A Zaharoulis; J E Gialafos; P K Toutouzas; E T Chimonas
Journal:  Eur Heart J       Date:  2001-05       Impact factor: 29.983

2.  Prognostic significance of multiple-detector computed tomography in conjunction with TIMI risk score for patients with non-ST elevation acute coronary syndrome.

Authors:  Mayumi Noda; Atsushi Takagi; Ryohei Kuwatsuru; Norio Mitsuhashi; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

3.  Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.

Authors:  Anthony A Bavry; Dharam J Kumbhani; Thomas J Helton; Przemyslaw P Borek; Girish R Mood; Deepak L Bhatt
Journal:  Am J Med       Date:  2006-12       Impact factor: 4.965

4.  Predictors of stent thrombosis after primary stenting for acute myocardial infarction.

Authors:  J A Silva; E Nuñez; C J White; T J Collins; J S Jenkins; S Zhang; S P Jain; S R Ramee
Journal:  Catheter Cardiovasc Interv       Date:  1999-08       Impact factor: 2.692

5.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

6.  Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.

Authors:  Stein Orn; John G F Cleland; Matti Romo; John Kjekshus; Kenneth Dickstein
Journal:  Am J Med       Date:  2005-07       Impact factor: 4.965

7.  Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.

Authors:  R Kornowski; U Goldbourt; M Zion; L Mandelzweig; E Kaplinsky; Y Levo; S Behar
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

8.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

9.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Authors:  A Schömig; F J Neumann; A Kastrati; H Schühlen; R Blasini; M Hadamitzky; H Walter; E M Zitzmann-Roth; G Richardt; E Alt; C Schmitt; K Ulm
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

Review 10.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Authors:  Christoph Stettler; Simon Wandel; Sabin Allemann; Adnan Kastrati; Marie Claude Morice; Albert Schömig; Matthias E Pfisterer; Gregg W Stone; Martin B Leon; José Suarez de Lezo; Jean-Jacques Goy; Seung-Jung Park; Manel Sabaté; Maarten J Suttorp; Henning Kelbaek; Christian Spaulding; Maurizio Menichelli; Paul Vermeersch; Maurits T Dirksen; Pavel Cervinka; Anna Sonia Petronio; Alain J Nordmann; Peter Diem; Bernhard Meier; Marcel Zwahlen; Stephan Reichenbach; Sven Trelle; Stephan Windecker; Peter Jüni
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321

View more
  3 in total

1.  A case of subacute thrombosis associated with clopidogrel resistance after implantation of a zotarolimus-eluting stent.

Authors:  Mizuhiro Arima; Atsushi Matsuda; Manabu Nitta; Keiko Yoshida; Makoto Shimizu
Journal:  Heart Vessels       Date:  2011-03-29       Impact factor: 2.037

2.  Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up).

Authors:  Nobutaka Ikeda; Rintaro Nakajima; Makoto Utsunomiya; Masaki Hori; Hideki Itaya; Kunihiko Makino; Tsuyoshi Ono; Masaya Yamamoto; Naohiko Nemoto; Raisuke Iijima; Hidehiko Hara; Takuro Takagi; Hisao Hara; Masato Nakamura; Kaoru Sugi
Journal:  Heart Vessels       Date:  2011-01-07       Impact factor: 2.037

3.  Comparison of the pathways of care and life courses between first-time ST-elevation myocardial infarction (STEMI) and STEMI with prior MI: findings from the OSCAR registry.

Authors:  Laurie Fraticelli; Olivier Kleitz; Clément Claustre; Nicolas Eydoux; Alexandra Peiretti; Karim Tazarourte; Eric Bonnefoy-Cudraz; Claude Dussart; Carlos El Khoury
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.